Rextovy Spray
Product Images NDC 76329-3669

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rextovy (NDC 76329-3669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by International Medication Systems, Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

REXTOVY Naloxone HCl Nasal Spray 4 mg/.25 mL nasal spray carton label by International Medication Systems, Ltd. The label includes dosing instructions, warnings, and storage conditions. It specifies use for nasal administration only and highlights that the product is intended for suspected opioid overdose. The package also features a foldable box design with instructional illustrations for use.*

FDA Label Image

Figure1 (Figure1)

Illustration showing the components of a REXTOVY Naloxone Hydrochloride Nasal Spray device, 4 mg/.25 mL. It highlights the nozzle, body labeled with the drug name and strength, finger flange, and a green plunger marked as unused.*

FDA Label Image

Figure2a (Figure2a)

A pharmacokinetic curve graph depicting naloxone plasma concentration (ng/mL) over time (hours) following different administration routes and doses: 4 mg intranasal spray, 0.4 mg intramuscular injection, and 2 mg intravenous injection. The graph illustrates plasma concentration changes within 6 hours post-dose.*

FDA Label Image

Figure2b (Figure2b)

A line graph depicting plasma concentrations of Naloxone over time following different administration routes and dosages. The x-axis represents time in hours, and the y-axis shows naloxone plasma concentration in ng/mL. It compares 4 mg naloxone given intranasally (one spray), 0.4 mg intramuscularly, and 2 mg intravenously, illustrating concentration profiles for each.*

FDA Label Image

Ifu Instructions (Ifu Instr)

Instructional diagram for administering REXTOVY Naloxone Hydrochloride Nasal Spray 4 mg/.25 mL. The eight-step illustrated guide covers laying the person flat, preparing the spray by peeling the blister pack, inserting the nozzle into one nostril, pushing the green plunger to release the dose, calling emergency services, watching the person for response, administering a second dose if needed using the opposite nostril, and disposing of the used spray. Visual aids depict head positioning, spray device components, and emergency actions.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Naloxone Hydrochloride, showing the molecular arrangement with marked chemical bonds and functional groups as part of the active ingredient's representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.